Filing Details
- Accession Number:
- 0001209191-21-014743
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-26 16:20:32
- Reporting Period:
- 2021-02-24
- Accepted Time:
- 2021-02-26 16:20:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Patient Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-24 | 2,946 | $217.57 | 43,719 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-02-25 | 922 | $211.56 | 42,797 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 1,460 | $213.30 | 41,337 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 668 | $214.19 | 40,669 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 336 | $215.56 | 40,333 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 200 | $216.62 | 40,133 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 882 | Indirect | 401(k) |
| Common Stock | 7,368 | Indirect | Held in trust |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $211.56 (range $211.06 to $211.87).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $213.30 (range $212.93 to $213.88).
- Open market sales reported on this line occurred at a weighted average price of $214.19 (range $213.94 to $214.78).
- Open market sales reported on this line occurred at a weighted average price of $215.56 (range $215.12 to $215.85).
Billionaire Hedge Funds
